Ingelheim – The Company Headquarters
Located within proximity to Frankfurt, Ingelheim has been hosting the headquarters of Boehringer Ingelheim ever since the foundation of the company in 1885. At that time, Albert Boehringer purchased a small tartaric acid factory. Over the course of the 20th century, the company gradually expanded from Ingelheim to become one of the leading, research-driven biopharmaceutical companies in the world. Today, more than 9,500 employees work at the Ingelheim site in Production, Research, Development, and Administration.
On these vast company grounds with more than 762,000 square meters, Boehringer Ingelheim produces various pharmaceuticals, including SPIRIVA® inhalation capsules, the oral anticoagulant PRADAXA® as well as the diabetes medications SYNJARDY® and JENTADUETO®. Within the company’s global production network, Ingelheim is also responsible for the production of all new active ingredients and medications during the market launch.